Nivolumab Improves Survival for Patients With Advanced Lung Cancer

Cancer - United States
doi 10.1002/cncr.30930
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Maintenance Therapy Improves Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer

Lung
PulmonaryRespiratory Medicine
2015English

MA10.06 Impact of Immune-Related Adverse Events on Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab

JAMA Oncology
Cancer ResearchOncology
2019English

Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non‐Small Cell Lung Cancer Patients

Oncologist
Cancer ResearchMedicineOncology
2018English

P3.01-17 Long Survivors With Advanced Lung Cancer - Efficacy and Tolerability of Nivolumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

CPC-017 Analysis of Survival in Patients With Advanced Non-Small Cell Lung Cancer

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Immunotherapy at Any Line of Treatment Improves Survival in Patients With Advanced Metastatic Non‐small Cell Lung Cancer (NSCLC) Compared With Chemotherapy (Quijote‐CLICaP)

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

JAMA Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy